BIOCYTOGEN ENTERS INTO NON-EXCLUSIVE LICENSING AGREEMENT WITH QILU PHARMACEUTICAL FOR A FULLY HUMAN VHH ANTIBODY TO SUPPORT INNOVATIVE DRUG DEVELOPMENT IN NEUROSCIENCE

Reuters · 3d ago

Please log in to view news